Comparative Study of Transvesical and Retropubic Prostatic Adenomectomies in the Urology-Andrology Department of Ignace Deen University Hospital Center
Objective: To compare the results of transvesical and retropubic prostatic adenomectomies at the Urology-Andrology Department of Conakry University Hospital. Methodology: This was a prospective multi-operator analytical study lasting 6 months. It included 70 patients operated on for benign prostatic hypertrophy (BPH), divided into 2 groups of 35 according to the retropubic or transvesical technique. The data was collected using a questionnaire and entered into the Epi info application. The analysis was initially descriptive and then univariate. To identify confounding factors, a multivariate analysis was performed. The application conditions of each test were checked before their application. A p-value < 0.05 was considered statistically significant. Results: Upper adenomectomies represented 53.6% of surgeries performed for BPH. The average age was 73.2 years. The mean prostate volume was 117 ± 51.6 cc and the mean total PSA was 9.2 ± 11.4 ng/ml. The majority of patients had an ASA1 (60%) and ASA2 (37.1%) score. Spinal anesthesia, a double-current silicone probe with hinged hinge 22, and drainage of the prevesical space were carried out in all patients, i.e. 100%. The average overall blood loss was 229 ± 98.2 ml. It was lower in the group of patients operated via the retropubic route (187 ± 60.4 ml). The same was true for the duration of intervention (49.1 ± 7.17 vs 55.4 ± 7.9 min), the catheter wearing time (5.14 ± 0.97 vs 9.29 ± 2 .9 days) and the length of hospitalization (=6.26 ± 1.15 vs 12.1 ± 5.74 days). Conclusion: The retropubic technique has advantages over the transvesical one. These advantages are translated by a gain in the duration of the intervention, blood loss, catheter wearing time and length of hospitalization.
References
[1]
Joseph, E. and Oesterling, J.E. (1998) Retropubic and Suprapubic Prostatectomy, Campbell’s Urology Philadelphia, Saunders, 2, 1529-1541.
[2]
Thorpe, A. and Neal, D. (2003) Benign Prostatic Hyperplasia. The Lancet, 361, 1359-1367. https://doi.org/10.1016/S0140-6736(03)13073-5
[3]
Fourcade, R.O., Picot, M.C., Gaudin, A.F., Texier, N. and Slama, A. (2007) Factors Determining Treatment Strategies for Patients with Benign Prostatic Hyperplasia: The DUO Study. La Presse Médicale, 36, 755-763. https://doi.org/10.1016/j.lpm.2006.12.027
[4]
Desgrandchamps, F., de la Taille, A., Azzouzi, A.R., Fourmarier, M., Haillot, O., Lukacs, B., et al. (2007) Medical Management of Uncomplicated Benign Prostatic Hyperplasia: A New Decision Algorithm. La Presse Médicale, 36, 475-480. https://doi.org/10.1016/j.lpm.2006.12.006
[5]
Freyer, P.J. (1900) A New Method of Performing Prostatectomy. British Medical Journal, 1, Article 698. https://doi.org/10.1136/bmj.1.2047.698-a
[6]
Fuller, E. (1895) Six Successful and Successive Cases of Prostatectomy. D. Appleton and Company, New York.
[7]
Reich, O., Gratzke, C., Bachmann, A., Seitz, M., Schlenker, B., Hermanek, P., et al. (2008) Morbidity, Mortality and Early Outcome of Transurethral Resection of the Prostate: A Prospective Multicenter Evaluation of 10,654 Patients. The Journal of Urology, 180, 246-249. https://doi.org/10.1016/j.juro.2008.03.058
[8]
Descazeaud, A., Robert, G. and de La Taille, A. (2018) Management of the Bladder Outlet Obstruction Associated with BPH in Patients with Special Circumstancesand/or Complications. Progrès en Urologie, 28, 868-874. https://doi.org/10.1016/j.purol.2018.08.006
[9]
Descazeaud, A., Robert, G., Delongchamps, N.B., Cornu, J.-N., Saussine, C., Haillot, O., et al. (2012) Initial Assessment, Follow-up and Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Guidelines of the LUTS Committee of the French Urological Association. Progrès en Urologie, 22, 977-988. https://doi.org/10.1016/j.purol.2012.10.001
[10]
Chakroun, M., Zouari, S., Saadi, A., Boussafa, H., Bouzouita, A., Derouiche, A., et al. (2020) Upper Adenomectomy in the Treatment of Benign Prostatic Hypertrophy. La Tunisie Médicale, 98, 967-971.
[11]
Barry II, M., Camara, A., Diallo, T.M.O., Bah, B.M., Bah, D.M. and Gnammi, L.R. (2021) Transurethral Resection of the Prostate at the Urology Department of Ignace Deen Hospital, Conakry, Guinea. International Journal of Clinical Urology, 5, 25-29. https://doi.org/10.11648/j.ijcu.20210501.16
[12]
Bah, I., Bah, M.B., Barry, M., Diallo, A., Kante, D. and Diallo, T.M.O. (2020) Transvesical Prostatic Adenomectomy: Results and Complications at the Urology Andrology Department of Ignace Deen Hospital, Conakry University Hospital. Health Sciences and Diseases, 1, 55-59.
[13]
Mathieu, R., Doizi, S., Bensalah, K., Lebacle, C., Legeais, D., Madec, F.-X., et al. (2022) Complications in Urological Surgery: Prostate Surgery. Progrès en Urologie, 32, 953-965. https://doi.org/10.1016/j.purol.2022.09.001
[14]
Miranda, E., Boillat, C. and Kherad, O. (2017) Urinary Catheter: Follow the Instructions to Avoid Infections. Revue Médicale Suisse, 13, 273-275. https://doi.org/10.53738/REVMED.2017.13.547.0273
[15]
Lebdai, S., Neuzillet, Y. and Descazeaud, A. (2023) Acute Retention of Urine. https://www.urofrance.org/sites/default/files/chapitre_20_item_342_-_ue_11_-_retention_aigue_durine.pdf
[16]
Bruyère, F., Cariou, G., Boiteux, J.P., et al. (2008) General Remarks. Progrès en Urologie, 18, 4-8. https://doi.org/10.1016/S1166-7087(08)70505-0
[17]
Ugwumba, F.O., Ozoemena, O.F., Okoh, A.D., Echetabu, K.N. and Mbadiwe, O.M. (2014) Transvesical Prostatectomy in the Management of Benign Prostatic Hyperplasia in a Developing Country. Nigerian Journal of Clinical Practice, 17, 797-801. https://doi.org/10.4103/1119-3077.144402
[18]
Kpatcha, T.M., Tchangai, B., Tengue, K., Alassani, F., Botcho, G., Darre, T., et al. (2016) Experience with Open Prostatectomy in Lomé, Togo. Open Journal of Urology, 6, 73-79. https://doi.org/10.4236/oju.2016.65014
[19]
Bagayogo, N.A., Faye, M., Sine, B., Sarr, A., Ndiaye, M., Ndiath, A., et al. (2021) Giant Benign Prostatic Hypertrophy (BPH): Epidemiological, Clinical and Therapeutic Aspects. African Journal of Urology, 27, 49-55. https://doi.org/10.21608/afju.2021.9359
[20]
Adakal, O., Rouga, M.M., Abdoulaye, M.B., Adamou, H., Maikassoua, M., Mounkeila, I., et al. (2021) Benign Prostate Hypertrophy at the Maradi Regional Hospital Center: Clinical, Therapeutic and Prognostic Aspects. Health Sciences and Diseases, 22, 93-97.
[21]
Nataf, R., et al. (1975) The Place of Surgical Endoscopy in Urology. Acta Endoscopica, 5, 187-189. https://doi.org/10.1007/BF02973544
[22]
Klotz, F., et al. (2003) Endoscopy in Developing Countries. Acta Endoscopica, 33, 756-757. https://doi.org/10.1007/BF03002617
[23]
Lin, Y., Wu, X., Xu, A., et al. (2016) Transurethral Enucleation of the Prostate versus Transvesical Open Prostatectomy for Large Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. World Journal of Urology, 34, 1207-1219. https://doi.org/10.1007/s00345-015-1735-9
[24]
Madersbacher, S., Lackner, J., Brossner, C., et al. (2005) Reoperation, Myocardial Infarction and Mortality after Transurethral and Open Prostatectomy: A Nation-Wide, Long-Term Analysis of 23123 Cases. European Urology, 47, 499-504. https://doi.org/10.1016/j.eururo.2004.12.010
[25]
Hubert, J., Cormier, P.F., Gerbaud, F., Guillemin, J.P., Pertek, J.P. and Mangin, P. (1996) Computer-Controlled Monitoring of Bladder Pressure in the Prevention of ‘TURP Syndrome’: A Randomized Study of 53 Cases. British Journal of Urology, 78, 228-233. https://doi.org/10.1046/j.1464-410X.1996.09815.x
[26]
Holman, C.D., Wisniewski, Z.S., Semmens, J.B., Rouse, I.L. and Bass, A.J. (1999) Mortality and Prostate Cancer Risk in 19598 Men after Surgery for Benign Prostatic Hyperplasia. BJU International, 84, 37-42. https://doi.org/10.1046/j.1464-410x.1999.00123.x
[27]
Doré, B. and Irani, J. (2001) Open Surgery for Benign Prostatic Hyperplasia. Route Transvesical, Retropubic Approach. EncyclMédChir (Scientific and Medical Editions Elsevier SAS, Paris, All Rights Reserved), Surgical Techniques, Urology, 1-13.
